Predicting red breast syndrome after ADM-assisted breast reconstruction: An exploratory scoring model using routine hematologic markers
PLOS One · 2026
DOI: 10.1371/journal.pone.0359415 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Dong Hun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Mammaplasty, Acellular Dermis, Postoperative Complications, Breast Diseases. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Red breast syndrome (RBS) is a challenging complication of acellular dermal matrix (ADM)-assisted breast reconstruction. Its incidence and hematologic predictors in patients receiving neoadjuvant chemotherapy (NAC) remain poorly characterized.
Methods
This retrospective cohort study included 70 patients who underwent skin-sparing mastectomy with immediate implant-based reconstruction following NAC (January 2011–May 2025) at a single tertiary institution. Patients were stratified into ADM (n = 47) and Non-ADM (n = 23) groups. Within the ADM group, Firth penalized logistic regression with backward elimination identified preoperative variables independently associated with RBS. Optimal cutoffs were determined by the Youden Index. A composite hematologic scoring model (WBC + PLT + Ki-67 High, cutoff ≥2) was developed and internally validated using bootstrap resampling (2,000 iterations).
Results
RBS occurred in 31.9% (15/47) of ADM patients versus 0% in Non-ADM patients ( p = 0.001). The final model identified WBC (OR 1.235, 95% CI 1.066–1.502, p = 0.004), PLT (OR 1.013, 95% CI 1.001–1.028, p = 0.037), and Ki-67 High (OR 8.975, 95% CI 1.356–155.173, p = 0.020) as independently associated with RBS. Individual biomarkers showed modest discrimination (AUC 0.605–0.641, all p > 0.10), while the composite score achieved AUC = 0.816 ( p < 0.001; sensitivity 86.7%, specificity 71.9%, NPV 92.0%). Bootstrap-corrected AUC was 0.817 (95% CI 0.636–0.959; optimism=−0.001). No significant temporal trend in RBS incidence was observed (Cochran–Armitage, p = 0.527).
Conclusions
RBS incidence is substantially elevated in post-NAC ADM patients. This exploratory, single-center study develops a hypothesis-generating combination score for preoperative RBS risk stratification using routine laboratory and pathology assessment. External validation in prospective multi-institutional cohorts is required before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
- Department of Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
- Department of Neurosurgery, Busan Paik Hospital, Busan, Republic of Korea.
ORCID-Profile: Dong Hun Lee, Hee Yeon Kim
Zitieren
APA
Lee, D. H., Byun, K. D., Kim, T. H., Lee, J., Yun, J., & Kim, H. Y. (2026). Predicting red breast syndrome after ADM-assisted breast reconstruction: An exploratory scoring model using routine hematologic markers. PLOS One. https://doi.org/10.1371/journal.pone.0359415
Vancouver
Lee DH, Byun KD, Kim TH, Lee J, Yun J, Kim HY. Predicting red breast syndrome after ADM-assisted breast reconstruction: An exploratory scoring model using routine hematologic markers. PLOS One. 2026. doi:10.1371/journal.pone.0359415
BibTeX
@article{Lee2026,
author = {Lee, Dong Hun and Byun, Kyung Do and Kim, Tae Hyun and Lee, Jin and Yun, Jiyoung and Kim, Hee Yeon},
title = {Predicting red breast syndrome after ADM-assisted breast reconstruction: An exploratory scoring model using routine hematologic markers},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0359415}
}
EUVIMED